Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New exclusive UK distribution agreements secured

18 Apr 2024 07:00

RNS Number : 0497L
Surgical Innovations Group PLC
18 April 2024
 

Surgical Innovations Group plc

("Surgical Innovations", the "Company", or the "Group")

 

New exclusive UK distribution agreements secured

Five-year contract signed with Microline Surgical

Three-year deal confirmed with Peters Surgical

 

Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative technology for minimally invasive surgery, announces it has agreed two new UK distribution contracts. The first is a five-year exclusive contract with Microline Surgical Inc ("Microline"), Boston, USA, and the second is a three-year exclusive arrangement with Peters Surgical (Peters), based in Paris, France.

 

The new agreement with Microline continues a relationship which started in 2007 with Elemental distributing the Microline portfolio of products in the UK. The new contract continues the distribution of Microline products by Elemental for a further five years and, at the current run rate, will be worth an estimated £9m in sales over the period of the contract. In 2021, the relationship with Microline was expanded under a separate five-year contract lasting into H1 2026, for the distribution of Surgical Innovations' YelloPort access devices in the USA via Microline's local direct sales team.

 

Elemental's agreement with Peters has an estimated sales value in excess of £1.5m over the contract period. It was announced in March 2024 that Advanced Medical Solutions plc (AMS), with whom Surgical Innovations has a trading relationship dating back to 2014, has entered into an agreement for the proposed acquisition of Peters Surgical. SI designed, and continues to manufacture, AMS's Fix8 laparoscopic glue device for the fixation of hernia mesh.

 

David Marsh, CEO of Surgical Innovations Group plc, said: "The renewal of both these agreements is a clear demonstration of the confidence that suppliers have in our UK Elemental sales team. The strength of these relationships is further underpinned through Microline and Peters' existing agreements to distribute Surgical Innovations branded products in the USA and India respectively."

 

About Microline Surgical Inc

Microline Surgical is a medical technology company specializing in the design, development, and manufacture of advanced surgical instruments. Microline Surgical offers a diverse range of surgical instruments, including graspers, dissectors, scissors, and specialized instruments tailored to specific surgical procedures. These instruments are designed to enhance surgical outcomes, improve customer's sustainability results, and reduce to cost of care. While the company is headquartered in the United States, it serves a global customer base, supplying surgical instruments to healthcare facilities and professionals worldwide.

 

About Peters Surgical

Peters Surgical is a manufacturer and distributor of high-quality surgical closure devices including sutures, titanium clips, clamps and surgical glues. The portfolio is focused on surgical specialties in the Cardiovascular ''CV'', Visceral, and Digestive Urology and Gynaecological ("DUG") surgical indication areas. Headquartered in France, Peters Surgical was founded in 1926 and today employs approximately 650 people around the world. Peters Surgical operates a fully integrated business model including research and product development, regulatory and clinical affairs, device manufacture, distribution, commercial and after-sales service. It owns manufacturing facilities in France, Thailand, India and Germany. Peters Surgical sells products in over 90 countries with direct sales infrastructure in France, USA, Germany, India, Poland and Belgium; and with a hybrid sales model in the APAC region.

 

For further information please contact:

 

Surgical Innovations Group plc

www sigroupplc com

David Marsh, CEO

Tel: 0113 230 7597

Singer Capital Markets (Nominated Adviser & Broker)

Tel: 020 7496 3000

Aubrey Powell / Oliver Platts

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus / Charlotte Edgar

 

Mob: 07980 541 893 / 07884 664 686

 

 

About Surgical Innovations Group plc

The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.

 

We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.

 

Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction.

 

In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.

 

We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.

 

Further information

Further details of the Group's businesses and products are available on the following websites:

www.sigroupplc.com

www.surginno.com

www.elementalhealthcare.co.uk

 

To receive regular updates by email, please contact si@walbrookpr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTGPUMUCUPCPGM
Date   Source Headline
25th Sep 202011:50 amRNSHolding(s) in Company
23rd Sep 20205:20 pmRNSHolding(s) in Company
21st Sep 20201:46 pmRNSHolding(s) in Company
18th Sep 20204:08 pmRNSResult of AGM
17th Sep 202012:54 pmRNSResult of Fundraise
17th Sep 20207:01 amRNSProposed Fundraise
8th Sep 20207:00 amRNSHalf-year Report
21st Aug 20207:00 amRNSNotice of results and Change of AGM 2020 Date
10th Aug 20205:57 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSPostponement of the Annual General Meeting 2020
4th Jun 20204:50 pmRNSDirector/PDMR Shareholding
4th Jun 20207:00 amRNSNHS Sustainability Webinar
28th May 20207:00 amRNSUpdate on trading &extension to banking facilities
31st Mar 20207:00 amRNSFinal Results
27th Mar 20203:05 pmRNSNotice of results and trading update
13th Jan 20207:00 amRNSYear-end Trading Update
11th Nov 20196:09 pmRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 20192:56 pmRNSDirector/PDMR Shareholding
25th Oct 20193:12 pmRNSDirector/PDMR Shareholding
7th Oct 20194:12 pmRNSHolding(s) in Company
27th Sep 20193:40 pmRNSExercise of Options, Issue of Equity and TVR
17th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSNotice of Results
19th Jun 20194:03 pmRNSResult of AGM
19th Jun 20197:00 amRNSBoard and management structure changes
7th Jun 20197:00 amRNSTrading Update
6th Jun 20192:00 pmRNSHolding(s) in Company
29th May 20193:06 pmRNSExercise of Options, PDMR Shareholding & TVR
23rd May 201910:38 amRNSHolding(s) in Company
22nd May 201910:16 amRNSHolding(s) in Company
13th May 20196:25 pmRNSNotification of Major Interest in Shares
27th Mar 20197:00 amRNSGrant of Options
15th Mar 20194:27 pmRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSFinal Results
28th Feb 20196:18 pmRNSExercise of Options & Total Voting Rights
28th Feb 20197:00 amRNSAppointment of CEO & changes in senior management
27th Feb 20197:00 amRNSNotice of Results
20th Feb 20197:00 amRNSUpdate on contingency planning for no-deal Brexit
14th Jan 20197:00 amRNSYear-end Trading Update
3rd Dec 20187:00 amRNSAppointment of Nominated Adviser and Broker
6th Nov 20187:00 amRNSSurgical robot technology UK distribution deal
16th Oct 201810:53 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSCE mark certification obtained for CELLIS range
11th Sep 201810:23 amRNSDirector/PDMR Shareholding
11th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSCE mark validation indicated for CELLIS range
22nd Aug 20187:00 amRNSNotice of Results
26th Jun 20184:41 pmRNSResult of AGM
26th Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.